Mallinckrodt Inc. to Present at Morgan Stanley Global Healthcare Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Mallinckrodt (NYSE: MNK), a leading global specialty pharmaceuticals and global medical imaging company, will present at the Morgan Stanley Global Healthcare Conference in New York City on Monday, September 9, 2013. Mark Trudeau, President and Chief Executive Officer of Mallinckrodt, will represent the Company in a session scheduled to begin at 1:15 PM EDT.

Help employers find you! Check out all the jobs and post your resume.

Back to news